Drug Therapy

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Matt T. Rosenberg, MD
Director, MidMichigan Health Centers, Jackson, MI

Roger R. Dmochowski, MD
Department of Urologic Surgery, Vanderbilt University School of Medicine, Nashville, TN

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Bryson Borg, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Brian R. Herts, MD
Department of Diagnostic Radiology, The Cleveland Clinic Foundation

Thomas J. Masaryk, MD
Head, Section of Neuroradiology, Department of Diagnostic Radiology, and the Department of Neurologic Surgery, The Cleveland Clinic Foundation

Address: Bryson Borg, MD, Department of Diagnostic Radiology, Hb6, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Matthew A. Hook, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin J. Brener, MD
Director, Core Angiography Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine

Address: Sorin J. Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Matthew A. Hook, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin J. Brener, MD
Director, Core Angiography Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine

Address: Sorin J. Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Juhana Karha, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Matthew A. Hook, MD
Department of Cardiovascular Medicine, The Cleveland Clinic Foundation

Sorin J. Brener, MD
Director, Core Angiography Laboratory, Department of Cardiovascular Medicine, The Cleveland Clinic Foundation; Associate Professor of Medicine, Cleveland Clinic Lerner College of Medicine

Address: Sorin J. Brener, MD, Department of Cardiovascular Medicine, F25, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

George E. Tesar, MD
Department of Psychiatry and Psychology, The Cleveland Clinic Foundation

Address: George E. Tesar, MD, Department of Psychiatry and Psychology, P57, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.